相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ESR1 mutations: Moving towards guiding treatment decision-making in metastatic breast cancer patients
Lindsay Angus et al.
CANCER TREATMENT REVIEWS (2017)
Linc-RoR promotes c-Myc expression through hnRNP I and AUF1
Jianguo Huang et al.
NUCLEIC ACIDS RESEARCH (2016)
LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer
X. Xue et al.
ONCOGENE (2016)
AMPK Activation and Metabolic Reprogramming by Tamoxifen through Estrogen Receptor-Independent Mechanisms Suggests New Uses for This Therapeutic Modality in Cancer Treatment
Natalie A. Daurio et al.
CANCER RESEARCH (2016)
Targeted therapy for breast cancer and molecular mechanisms of resistance to treatment
Guowei Gu et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
Endocrine therapy and strategies to overcome therapeutic resistance in breast cancer
Michael Robert Mancuso et al.
CURRENT PROBLEMS IN CANCER (2016)
Egr-1 promotes hypoxia-induced autophagy to enhance chemo-resistance of hepatocellular carcinoma cells
Wan-xin Peng et al.
EXPERIMENTAL CELL RESEARCH (2016)
LncPRESS1 Is a p53-Regulated LncRNA that Safeguards Pluripotency by Disrupting SIRT6-Mediated De-acetylation of Histone H3K56
Abhinav K. Jain et al.
MOLECULAR CELL (2016)
Long Non-Coding RNA (lncRNA) Urothelial Carcinoma-Associated 1 (UCA1) Enhances Tamoxifen Resistance in Breast Cancer Cells via Inhibiting mTOR Signaling Pathway
Chihua Wu et al.
MEDICAL SCIENCE MONITOR (2016)
Regulatory Roles of MAPK Phosphatases in Cancer
Heng Boon Low et al.
IMMUNE NETWORK (2016)
Review of hormone-based treatments in postmenopausal patients with advanced breast cancer focusing on aromatase inhibitors and fulvestrant
Iben Kumler et al.
ESMO OPEN (2016)
Small Molecule Inhibition of ERK Dimerization Prevents Tumorigenesis by RAS-ERK Pathway Oncogenes
Ana Herrero et al.
CANCER CELL (2015)
Estrogen receptor alpha phosphorylation and its functional impact in human breast cancer
Muralidharan Anbalagan et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
lincRNA-RoR and miR-145 Regulate Invasion in Triple-Negative Breast Cancer via Targeting ARF6
Gabriel Eades et al.
MOLECULAR CANCER RESEARCH (2015)
Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA
Erin L. Hayes et al.
BREAST CANCER RESEARCH (2015)
MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway
Xiang-Song Wu et al.
CANCER BIOLOGY & THERAPY (2014)
SPOP Promotes Tumorigenesis by Acting as a Key Regulatory Hub in Kidney Cancer
Guoqiang Li et al.
CANCER CELL (2014)
MACROD2 overexpression mediates estrogen independent growth and tamoxifen resistance in breast cancers
Morassa Mohseni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage
Ali Zhang et al.
CELL RESEARCH (2013)
Dual-specificity MAP kinase phosphatases (MKPs): Shaping the outcome of MAP kinase signalling
Christopher J. Caunt et al.
FEBS JOURNAL (2013)
Endocrine therapy: is the first generation of targeted drugs the last?
K. I. Pritchard
JOURNAL OF INTERNAL MEDICINE (2013)
Efficient genome editing in zebrafish using a CRISPR-Cas system
Woong Y. Hwang et al.
NATURE BIOTECHNOLOGY (2013)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
LncRNA loc285194 is a p53-regulated tumor suppressor
Qian Liu et al.
NUCLEIC ACIDS RESEARCH (2013)
ARF triggers senescence in Brca2-deficient cells by altering the spectrum of p53 transcriptional targets
Ana Rita Carlos et al.
NATURE COMMUNICATIONS (2013)
High ERK Protein Expression Levels Correlate with Shorter Survival in Triple-Negative Breast Cancer Patients
Chandra Bartholomeusz et al.
ONCOLOGIST (2012)
MicroRNA-101-mediated Akt activation and estrogen-independent growth
M. Sachdeva et al.
ONCOGENE (2011)
Long noncoding RNAs and human disease
Orly Wapinski et al.
TRENDS IN CELL BIOLOGY (2011)
Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells
Sabine Loewer et al.
NATURE GENETICS (2010)
EGFRvIII-induced estrogen-independence, tamoxifen-resistance phenotype correlates with PgR expression and modulation of apoptotic molecules in breast cancer
Yang Zhang et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Estrogen Receptor-α Phosphorylation at Serine-118 and Tamoxifen Response in Breast Cancer
Marleen Kok et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Low phosphorylation of estrogen receptor a (ER alpha) serine 118 and high phosphorylation of ER alpha serine 167 improve survival in ER-positive breast cancer
Hiroko Yamashita et al.
ENDOCRINE-RELATED CANCER (2008)
A functional serine 118 phosphorylation site in estrogen receptor-α is required for down-regulation of gene expression by 17β-estradiol and 4-hydroxytamoxifen
Jingwei Cheng et al.
ENDOCRINOLOGY (2007)
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
James A. McCubrey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases
D. M. Owens et al.
ONCOGENE (2007)
MAP kinase signalling pathways in cancer
A. S. Dhillon et al.
ONCOGENE (2007)
miR-21-mediated tumor growth
M.-L. Si et al.
ONCOGENE (2007)
Gam1-associated alterations of drug responsiveness through activation of apoptosis
Fangting Wu et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activity
Varsha S. Likhite et al.
MOLECULAR ENDOCRINOLOGY (2006)
Coordinating ERK/MAPK signalling through scaffolds and inhibitors
W Kolch
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Mechanisms of tamoxifen resistance: Increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer
J Shou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Phosphorylation of human estrogen receptor α at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera
DS Chen et al.
ONCOGENE (2002)
Intracellular signaling pathways: Nongenomic actions of estrogens and ligand-independent activation of estrogen receptors
KM Coleman et al.
FRONTIERS IN BIOSCIENCE (2001)
分享论文
